Clinical Trials - Desmoid Tumor Research Foundation
Menu

Clinical Trials

Please be aware that this page may not always be current. Updated information regarding clinical trials can be found searching for “desmoid tumor” at the National Cancer Institute’s website.

THE FOLLOWING ARE ONGOING OR RECENTLY CLOSED TRIALS INCLUDING DESMOIDS:

[wp_rss_aggregator limit="10" links_before='
    ' link_before='

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
August 16, 2016
Provided by:
Ligue contre le cancer , France
ClinicalTrials.gov #:
NCT02867033
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)

Recruiting Status:
Last Updated:
July 12, 2016
Provided by:
ClinicalTrials.gov #:
NCT02495519
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
September 16, 2016
Provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov #:
NCT02476305
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

18F-FES PET/CT in Imaging Patients With Desmoid Tumors

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
January 12, 2017
Provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov #:
NCT02374931
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
September 10, 2015
Provided by:
Ministero della Salute, Italy
ClinicalTrials.gov #:
NCT02547831
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Recruiting Status:
Last Updated:
January 30, 2015
Provided by:
Associazione Italiana per la Ricerca sul Cancro
ClinicalTrials.gov #:
NCT02353429
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Recruiting Status:
Last Updated:
April 21, 2017
Provided by:
ClinicalTrials.gov #:
NCT02066181
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis

Recruiting Status:
Last Updated:
April 20, 2017
Provided by:
ClinicalTrials.gov #:
NCT01981551
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
October 30, 2013
Provided by:
michal roll, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov #:
NCT01898416
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

PAZOPANIB Efficacy and Tolerance in Desmoids Tumors

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
May 25, 2016
Provided by:
Institut Bergonié
ClinicalTrials.gov #:
NCT01876082
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome

Recruiting Status:
Last Updated:
January 27, 2011
Provided by:
ClinicalTrials.gov #:
NCT01286662
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
April 20, 2017
Provided by:
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov #:
NCT01273168
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis

Recruiting Status:
This study is currently recruiting participants.
Last Updated:
April 5, 2017
Provided by:
Desmoid Tumor Research Foundation
ClinicalTrials.gov #:
NCT01265030
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Study to Evaluate Imatinib in Desmoid Tumors

Recruiting Status:
Last Updated:
October 24, 2016
Provided by:
Information provided by (Responsible Party):
ClinicalTrials.gov #:
NCT01137916
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Imatinib in Patients With Desmoid Tumor and Chondrosarcoma

Recruiting Status:
Last Updated:
September 9, 2016
Provided by:
ClinicalTrials.gov #:
NCT00928525
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All

Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis

Recruiting Status:
Last Updated:
August 29, 2016
Provided by:
ClinicalTrials.gov #:
NCT00287846
Sex/
Gender:
Sexes Eligible for Study: All
Sexes Eligible for Study: All
  TOP